Eli Lilly pledges $40 million to Indiana University to expand clinical trials
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Plans underway to expand screening capacity by 50% for greater accessibility
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Subscribe To Our Newsletter & Stay Updated